QIAGEN (Suzhou) Translational Medicine Co


About QIAGEN (Suzhou) Translational Medicine Co

QIAGEN (Suzhou) Translational Medicine Co. (TMC) Ltd. is the first diagnostic R&D company focused on translational science in China. The company provides complete solutions for precision medicine through translational science. Jointly established by QIAGEN and China SIP Biotechnology Development Co. Ltd., QIAGEN (Suzhou) TMC’s mission is the development and validation of biomarkers and companion diagnostics as well as patient stratification for clinical trials.

Therapeutic Areas



Diagnostics Drug delivery

Company Type

Biotechnology – Diagnostics

State of Ownership


Influencer Of